Human Chimeric IRF-7/IRF-3 Plasmid Adjuvant (VCar-Ly035)
| CAT | Size | Price | Quantity | |
|---|---|---|---|---|
| VCar-Ly035 |
|
Express a human super-activated IRF7/3 chimeric gene.
Datasheet
Specifications
Source
Human super-activated chimeric IRF-7/IRF-3 gene
Target
DVA vaccine
Type
Dendrimers&Cyclopeptides
Applications
For DNA vaccine delivery.
Quantity
20 µg
Antigen Information
Introduction
The cIRF7/3 plasmids express the super-activated IRF7/3 chimeric gene. The IRF-3/IRF-7 chimeric gene delivery system is an immune activation tool designed by genetically engineering the key functional domains of two interferon regulators (IRF-3 and IRF-7). Its core role is to simulate the virus invasion signal and directly activate the rapid expression of interferon (IFN-α/β) and its downstream antiviral genes, while bypassing the dependence on traditional pattern recognition receptors.
Related Product
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
